Preexposure Intradermal Rabies Vaccination: A Noninferiority Trial in Healthy Adults on Shortening the Vaccination Schedule From 28 to 7 Days | Zendy

Patrick Soentjens | Zendy; Petra Andries | Zendy; Annelies Aerssens | Zendy; Achilleas Tsoumanis | Zendy; Raffaela Ravinetto | Zendy; Walter Heuninckx | Zendy; Harry van Loen | Zendy; B. Brochier | Zendy; Steven Van Gucht | Zendy; Pierre Van Damme | Zendy; Yven Van Herrewege | Zendy; Emmanuel Bottieau | Zendy

Open Access

Preexposure Intradermal Rabies Vaccination: A Noninferiority Trial in Healthy Adults on Shortening the Vaccination Schedule From 28 to 7 Days

Author(s) -

Patrick Soentjens,

Petra Andries,

Annelies Aerssens,

Achilleas Tsoumanis,

Raffaela Ravinetto,

Walter Heuninckx,

Harry van Loen,

B. Brochier,

Steven Van Gucht,

Pierre Van Damme,

Yven Van Herrewege,

Emmanuel Bottieau

Publication year - 2018

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciy513

Subject(s) - medicine , vaccination , rabies , booster dose , booster (rocketry) , immunogenicity , rabies vaccine , vaccination schedule , titer , adverse effect , clinical endpoint , immunology , pediatrics , antibody , clinical trial , virology , immunization , rabies virus , physics , astronomy

The existing 4-week preexposure rabies vaccination schedule is costly and often not practicable. Shorter effective schedules would result in wider acceptance.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research